Infectious Disease Diagnostics Market

Infectious Disease Diagnostics Market Size, Share & Trends Analysis Report by Product (Reagents, Kits, and Consumables, Instruments, Software & Services), by Type of Testing (Laboratory Testing, POC Testing), by Technology (Immunodiagnostics, Clinical Microbiology , PCR , INAAT ), by Disease Type (COVID-19, HIV , HAIs , Hepatitis ), by End User (Diagnostic Laboratories, Hospitals & Clinics , Academic Research Institutes , Other End Users), by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)

Frequently Asked Questions

  • What is the global demand for Infectious Disease Diagnostics in terms of revenue?

    The global Infectious Disease Diagnostics valued at 27,824.80 USD Million in 2020 and is expected to reach 41,291.40 USD Million in 2028 growing at a CAGR of 6.80%

  • Which are the prominent players in the market?

    The prominent players in the market are Abbott Laboratories (US), F. Hoffmann-La Roche Ltd(Switzerland), bioMérieux SA (France), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Quidel Corporation(US), Hologic, Inc. (US), Siemens Healthineers AG (Germany), Becton, Dickinson and Company (US), PerkinElmer Inc. (US), QIAGEN (Netherlands), Grifols S.A. (Spain), DiaSorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), Sysmex Corporation (Japan), Ortho Clinical Diagnostics (US), Luminex Corporation (US), Meridian Bioscience (US), Genetic Signatures (Australia), OraSure Technologies (US), Trinity Biotech Plc. (Ireland), Chembio Diagnostic Systems, Inc. (US), Seegene Inc. (South Korea), Co-Diagnostics, Inc. (US), ELITechGroup (France), Epitope Diagnostics, Inc. (US), Trivitron Healthcare (India), Meril Life Sciences Pvt. Ltd. (India), InBios International, Inc. (US), and ABACUS Diagnostica Oy (Finland)..

  • At what CAGR is the market projected to grow within the forecast period?

    The market is project to grow at a CAGR of 6.80% between 2021 and 2028.

  • What are the driving factors fueling the growth of the market.

    The driving factors of the Infectious Disease Diagnostics include

    • increasing prevalence of infectious diseases

  • Which region accounted for the largest share in the market?

    North America was the leading regional segment of the Infectious Disease Diagnostics in 2020.

Request Sample Buy Now